Crispr Genomic Cure Market
Description
Crispr Genomic Cure Market, By Disease Type (Genetic Disorders, Cancer, Infectious Diseases, Neurological Disorders, Cardiovascular Disorders, Blood Disorders, Metabolic Disorders, Other Diseases), By Therapy Type (Gene Editing, Gene Therapy, Cell Therapy, Immunotherapy), By Delivery Method (In vivo (directly into the patient's body), Ex vivo (modification of cells outside the body before reintroduction)), By Application (Therapeutic Applications, Research Applications), By End-User (Hospitals and Clinics, Research Institutes, Biotechnology and Pharmaceutical Companies), By Regulatory Status (Approved Therapies, Investigational Therapies) Targeted Genetic Modification (Single Gene Modification, Multiple Gene Modification, Genome-wide Modification), By Market Segment (Pediatric Patients, Adult Patients), By Awareness and Support Organizations (CRISPR-Cas9 Genome Editing Therapeutics Society, Genetic Disease Advocacy Organizations, Cancer Research, Foundations, Rare Disease Foundations, Biotechnology and Pharmaceutical Associations), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
CRISPR is a unique technology for the targeted editing and regulation of genes that can be applied to a number of biological systems. Researchers use CRISPR to alter genes in plant, bacteria, and animal models. It is widely used in disease model studies and helps in understanding the genetic basis of disease for development of better therapeutics. The technology enables rapid, economical model generation through precise genome editing that accurately recapitulates the disease. It has also been put to use as experimental test to detect the novel coronavirus. CRISPR is a technology that can be used to edit genes and, as such, will likely change the world.
Market Dynamics:
Increasing prevalence of chronic disease, genetic disease, infectious diseases, neurological disease, blood disease, and metabolic disease, growing geriatric population, growing demand for safe and effective treatment or therapies, increasing funding for cell and gene therapies, frequent approvals for gene therapies, introduction of novel therapies, and increasing awareness among people about Crispr genomic cure are major factors expected to augment growth of the global Crispr genomic cure market during the forecast period.
For instance, in March 2021, Scientists at UC San Francisco, UC Berkeley, and UCLA received the U.S. Food and Drug Administration (FDA) approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells. The therapy has the potential to transform sickle cell disease care by producing an accessible, curative treatment that is safer than the current therapy of stem cell transplant from a healthy bone marrow donor. Moreover, the therapy has the potential to prevent irreversible complications of the disease.
Key features of the study:
This report provides in-depth analysis of the global Crispr genomic cure market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Crispr genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Merck KgaA, Takara Bio Inc., Lonza Group Ltd., Horizon Discovery Group plc, GenScript Biotech Corporation, Synthego Corporation, Precision Biosciences, Inc., Mammoth Biosciences, Caribou Biosciences, Inc., Beam Therapeutics Inc., Sangamo Therapeutics, Inc., Intellia Therapeutics, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, and Thermo Fisher Scientific Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global Crispr genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Crispr genomic cure market.
Detailed Segmentation:
Global Crispr Genomic Cure Market, By Disease Type:
Genetic Disorders
Cancer
Infectious Diseases
Neurological Disorders
Cardiovascular Disorders
Blood Disorders
Metabolic Disorders
Other Diseases
Global Crispr Genomic Cure Market, By Therapy Type:
Gene Editing
Gene Therapy
Cell Therapy
Immunotherapy
Global Crispr Genomic Cure Market, By Delivery Method:
In vivo (directly into the patient's body)
Ex vivo (modification of cells outside the body before reintroduction)
Global Crispr Genomic Cure Market, By Application:
Therapeutic Applications
Research Applications
Global Crispr Genomic Cure Market, By End User:
Hospitals and Clinics
Research Institutes
Biotechnology and Pharmaceutical Companies
Global Crispr Genomic Cure Market, By Regulatory Status:
Approved Therapies
Investigational Therapies
Global Crispr Genomic Cure Market, By Targeted Genetic Modification:
Single Gene Modification
Multiple Gene Modification
Genome-wide Modification
Global Crispr Genomic Cure Market, By Market Segment:
Pediatric Patients
Adult Patients
Global Crispr Genomic Cure Market, By Awareness and Support Organizations:
CRISPR-Cas9 Genome Editing Therapeutics Society
Genetic Disease Advocacy Organizations
Cancer Research Foundations
Rare Disease Foundations
Biotechnology and Pharmaceutical Associations
Global Crispr Genomic Cure Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles:
Merck KgaA
Takara Bio Inc.
Lonza Group Ltd.
Horizon Discovery Group plc
GenScript Biotech Corporation
Synthego Corporation
Precision Biosciences, Inc.
Mammoth Biosciences
Caribou Biosciences, Inc.
Beam Therapeutics Inc.
Sangamo Therapeutics, Inc.
Intellia Therapeutics, Inc.
Editas Medicine, Inc.
CRISPR Therapeutics AG
Thermo Fisher Scientific Inc.
Table of Contents
150 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Therapy Type
- Market Snapshot, By Delivery Method
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Regulatory Status
- Market Snapshot, By Targeted Genetic Modification
- Market Snapshot, By Market Segment
- Market Snapshot, By Awareness and Support Organizations
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in global disease burden
- High cost of CRISPR
- High demand for safe/effective therapeutics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Crispr Genomic Cure Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Crispr Genomic Cure Market, By Disease Type, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Blood Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Other Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 6. Global Crispr Genomic Cure Market, By Therapy Type, 2020-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- Gene Editing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 7. Global Crispr Genomic Cure Market, By Delivery Method, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- In vivo (directly into the patient's body)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Ex vivo (modification of cells outside the body before reintroduction)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 8. Global Crispr Genomic Cure Market, By Application, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- Therapeutic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 9. Global Crispr Genomic Cure Market, By End User, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 10. Global Crispr Genomic Cure Market, By Regulatory Status, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- Approved Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Investigational Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 11. Global Crispr Genomic Cure Market, By Targeted Genetic Modification, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- Single Gene Modification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Multiple Gene Modification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Genome-wide Modification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 12. Global Crispr Genomic Cure Market, By Market Segment, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 13. Global Crispr Genomic Cure Market, By Awareness and Support Organizations, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- CRISPR-Cas9 Genome Editing Therapeutics Society
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Genetic Disease Advocacy Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cancer Research Foundations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Rare Disease Foundations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Biotechnology and Pharmaceutical Associations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 14. Global Crispr Genomic Cure Market, By Region, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 - 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Method, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Status, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Genetic Modification, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Market Segment, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Awareness and Support Organizations, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Method, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Status, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Genetic Modification, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Market Segment, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Awareness and Support Organizations, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Method, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Status, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Targeted Genetic Modification, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Market Segment, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Awareness and Support Organizations, 2023-2030,(US$ Bn)
- Latin America
- Middle East & Africa
- 15. Competitive Landscape
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc.
- Lonza Group Ltd.
- Horizon Discovery Group plc
- GenScript Biotech Corporation
- Synthego Corporation
- Precision Biosciences, Inc.
- Mammoth Biosciences
- Caribou Biosciences, Inc.
- Beam Therapeutics Inc.
- Sangamo Therapeutics, Inc.
- Intellia Therapeutics, Inc.
- Editas Medicine, Inc.
- CRISPR Therapeutics AG
- Thermo Fisher Scientific Inc.
- Analyst Views
- 16. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on "Global Crispr Genomic Cure Market” - forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
